- Home
- PLSE vs REAL Comparison
PLSE vs REAL Comparison
Compare PLSE & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLSE
- REAL
- Stock Information
- Founded
- PLSE 2014
- REAL 2011
- Country
- PLSE United States
- REAL United States
- Employees
- PLSE N/A
- REAL N/A
- Industry
- PLSE Medical/Dental Instruments
- REAL Other Specialty Stores
- Sector
- PLSE Health Care
- REAL Consumer Discretionary
- Exchange
- PLSE Nasdaq
- REAL Nasdaq
- Market Cap
- PLSE 1.1B
- REAL 1.2B
- IPO Year
- PLSE 2016
- REAL 2019
- Fundamental
- Price
- PLSE $18.12
- REAL $9.47
- Analyst Decision
- PLSE
- REAL Buy
- Analyst Count
- PLSE 0
- REAL 6
- Target Price
- PLSE N/A
- REAL $7.04
- AVG Volume (30 Days)
- PLSE 134.0K
- REAL 3.3M
- Earning Date
- PLSE 10-30-2024
- REAL 02-27-2025
- Dividend Yield
- PLSE N/A
- REAL N/A
- EPS Growth
- PLSE N/A
- REAL N/A
- EPS
- PLSE N/A
- REAL N/A
- Revenue
- PLSE N/A
- REAL $579,862,000.00
- Revenue This Year
- PLSE N/A
- REAL $11.26
- Revenue Next Year
- PLSE N/A
- REAL $8.81
- P/E Ratio
- PLSE N/A
- REAL N/A
- Revenue Growth
- PLSE N/A
- REAL 2.52
- 52 Week Low
- PLSE $6.60
- REAL $1.52
- 52 Week High
- PLSE $22.69
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- PLSE 49.47
- REAL 55.77
- Support Level
- PLSE $17.18
- REAL $9.21
- Resistance Level
- PLSE $19.90
- REAL $10.00
- Average True Range (ATR)
- PLSE 1.10
- REAL 0.59
- MACD
- PLSE 0.00
- REAL -0.13
- Stochastic Oscillator
- PLSE 30.70
- REAL 66.81
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.